BioWorld A closer look BioWorld Asia BioWorld Science

BioWorld

Apogee orbiting big AD market as Apex phase II data land
Apogee Therapeutics Inc. loaded up on what could total as much as $1.3 billion in financial fuel from Blackstone Life Sciences funds that will be used to propel...

More in BioWorld

BioWorld Science

Work underway on vaccines, antivirals against rare Bundibugyo Ebola outbreak
Less than two weeks after the outbreak was officially declared, animal studies of a newly designed vaccine against the Bundibugyo Ebola virus are now underway in the U.S....

More in BioWorld Science

A closer look

Ongoing coverage of the Ebola outbreak
Stay up to date as BioWorld reports on the latest developments of the Ebola virus public health emergency.

More in A closer look

BioWorld Asia

Hengrui, BMS deal watershed moment for China biotech
The recent multibillion-dollar licensing alliance between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd is not an outlier, but rather the clearest...

More in BioWorld Asia

BioWorld Insider podcast

The opioid crisis may not be front and center anymore, but it’s raging still. Elysium Therapeutics Inc. CEO Greg Sturmer talks about his firm’s candidate for a solution to the medical and societal problem.